This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Asia: Oligonucleotide & Peptide Therapeutics
26-28 Feb, 2025
Westin Miyako KyotoKyoto, Japan

Dr. Frederic Dargelas, PhD
Senior Director, Head of Business Development and Alliance Management at DelSiTech Ltd.
Presenter

Agenda Sessions

  • Biodegradable Silica Composite Technology Enabling Long-Acting Controlled Release of GLP-1RAs

    2:45pm